Veracyte (VCYT) Insider Trading & Ownership $34.83 -0.42 (-1.19%) (As of 09/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Veracyte (NASDAQ:VCYT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$1.60 M Get VCYT Insider Trade Alerts Want to know when executives and insiders are buying or selling Veracyte stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VCYT Insider Buying and Selling by Quarter Ad Porter & CompanyWar on Elon Escalates… One company holds a near-total monopoly on this technology. Elon Musk is one of the few people who knows this. That’s why in his recent interview with Trump, he brought up this technology as a viable solution to America’s growing energy needs. What is this technology and why has it put Elon in the middle of an ideological war with the elites?Watch my new exposé and find out. Veracyte Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/4/2024John LeiteInsiderSell5,479$29.78$163,164.62 8/13/2024Evan/ Fa JonesDirectorSell20,457$32.20$658,715.40 8/9/2024Evan/ Fa JonesDirectorSell1,032$30.03$30,990.96 8/7/2024Jens HolsteinDirectorSell5,000$29.00$145,000.00 7/16/2024John LeiteInsiderSell1,277$25.00$31,925.00 7/16/2024Karin EasthamDirectorSell7,500$25.00$187,500.00 The $15 "Insider Secret" That Could Save Your Retirement (Ad)What if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's right. You can grab shares of this potential retirement-maker for less than you'd pay for lunch.Click here to discover the name and ticker of this "$15 billionaire-backed retirement stock" >>>6/10/2024Muna BhanjiDirectorSell3,870$20.32$78,638.40 6/7/2024Karin EasthamDirectorSell2,500$20.97$52,425.00 5/28/2024Muna BhanjiDirectorSell1,539$21.00$32,319.00 4/1/2024Karin EasthamDirectorSell10,000$21.65$216,500.00 (Data available from 1/1/2013 forward) VCYT Insider Trading Activity - Frequently Asked Questions Who is on Veracyte's Insider Roster? The list of insiders at Veracyte includes Bonnie H Anderson, Evan/ Fa Jones, Giulia C Kennedy, Jens Holstein, John L Bishop, John Leite, Karin Eastham, Marc Stapley, and Muna Bhanji. Learn more on insiders at VCYT. What percentage of Veracyte stock is owned by insiders? 1.30% of Veracyte stock is owned by insiders. Learn more on VCYT's insider holdings. Which Veracyte insiders have been selling company stock? The following insiders have sold VCYT shares in the last 24 months: Bonnie H Anderson ($6,269,297.11), Evan/ Fa Jones ($922,279.93), Giulia C Kennedy ($53,285.37), Jens Holstein ($145,000.00), John L Bishop ($305,000.00), John Leite ($195,089.62), Karin Eastham ($456,425.00), and Muna Bhanji ($306,643.81). How much insider selling is happening at Veracyte? Insiders have sold a total of 331,048 Veracyte shares in the last 24 months for a total of $8,653,020.84 sold. Which members of congress are trading Veracyte? Josh Gottheimer (D-NJ) has bought shares of Veracyte in the last year totaling $8,000. Veracyte Key ExecutivesMr. Marc A. Stapley (Age 54)CEO & Director Compensation: $1.55MMs. Rebecca Chambers (Age 46)Executive VP & CFO Compensation: $901.49kDr. Phillip G. Febbo M.D. (Age 58)Chief Scientific & Medical Officer Compensation: $657.74kMs. Annie McGuire (Age 43)Executive VP, General Counsel & Chief People Officer Compensation: $791.72kDr. John Leite Ph.D. (Age 52)Chief Commercial Officer for CLIA Business Compensation: $1.53MMr. Jonathan Wygant (Age 53)VP & Chief Accounting Officer Mr. Steven FrenchSenior VP & Chief Information OfficerMs. Karen PossematoSenior Vice President of Corporate Marketing, Communications & Commercial OperationsMr. Robert Brainin (Age 53)Executive VP & Chief Business Officer Ms. Corinne DananSenior Vice President More Insider Trading Tools from MarketBeat Related Companies: PACS Group Insider Buying Option Care Health Insider Buying Sotera Health Insider Buying Surgery Partners Insider Buying Guardant Health Insider Buying Hims & Hers Health Insider Buying LifeStance Health Group Insider Buying BrightSpring Health Services Insider Buying Addus HomeCare Insider Buying Privia Health Group Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: This Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock This page (NASDAQ:VCYT) was last updated on 9/22/2024 by MarketBeat.com Staff From Our PartnersJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWall Street Insider Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veracyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veracyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.